Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 11/2016

01-11-2016 | Letter to the Editor

Correspondence on the article: “Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up”

Authors: Nasir Ali, Ahmed Nadeem Abbasi, Muhammad Atif Mansha

Published in: Medical Oncology | Issue 11/2016

Login to get access

Excerpt

Our team has gone through this article authored by Luvero et al. [1]. Certainly, 10-year follow-up of 90 cervical cancer patients is an impressive long-term follow-up. In this study, authors reported a negative correlation for involved nodes and outcome and also mentioned that site of involved nodes is not related to survival. Our team is inclined to disagree with this statement. In one study by Kidd et al. [2], it was reported that on PET/CT imaging the more distant level of nodal involvement was associated with poor survival. In another study by Paumier et al. [3], three-year survival was 58 and 24 % in patients without and with paraaortic lymph node involvement, respectively. These patients were staged by PET/CT. …
Literature
1.
Luvero D, Plotti F, Aloisi A, Capriglione S, Ricciardi R, Miranda A, et al. Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up. Med Oncol. 2016;33(10):110.CrossRefPubMed
2.
Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, et al. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol. 2010;28(12):2108–13.CrossRefPubMed
3.
Paumier A, Blanchard P, Mazeron R, Dumas I, Morice P, Lhomme C, et al. Outcome of cervical carcinoma with locoregional lymph node involvement by FDG-PET. Cancer Radiother. 2012;16(3):183–9.CrossRefPubMed
4.
Duenas-Gonzalez A, Zarba JJ, Patel F, Alcedo JC, Beslija S, Casanova L, et al. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol. 2011;29(13):1678–85.CrossRefPubMed
Metadata
Title
Correspondence on the article: “Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up”
Authors
Nasir Ali
Ahmed Nadeem Abbasi
Muhammad Atif Mansha
Publication date
01-11-2016
Publisher
Springer US
Published in
Medical Oncology / Issue 11/2016
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-016-0847-4

Other articles of this Issue 11/2016

Medical Oncology 11/2016 Go to the issue

Original Paper

Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma

Original Paper

A phase IIa study of rhLTα-Da in combination with cisplatin and fluorouracil for patients with metastatic esophageal squamous cell carcinoma or gastric adenocarcinoma

Original Paper

7SK small nuclear RNA transcription level down-regulates in human tumors and stem cells

Original Paper

Expression of the anaphylatoxin C5a receptor in gastric cancer: implications for vascular invasion and patient outcomes

Original Paper

Downregulation of Foxo3 and TRIM31 by miR-551b in side population promotes cell proliferation, invasion, and drug resistance of ovarian cancer

Original Paper

Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits